Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ...
BARCELONA, Spain, /PRNewswire/ -- Grifols, S.A. ("Grifols (GRFS)"), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its ...
A Calgary centre that pays people for their plasma was designated as “non-compliant” by Health Canada in December for violating rules regulating the country’s blood supply, and the revelation is ...
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
The Corner: Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Link Securities | Grifols (GRF) plans to make an early repayment of €500 million of its 7.5% senior secured bonds maturing in 2030. This transaction would ...
Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...
Spanish plasma medicines producer Grifols is clapping back at Gotham City Research, filing a lawsuit that accuses the New York hedge fund of “knowingly making false and misleading statements” about ...
Seeking Alpha: Grifols 2023 Annual Report on Form 20-F filed with the SEC
Paypal Home. Shopping online shouldn't cost you peace of mind. Buy from millions of online stores without sharing your financial information.
Send Money, Pay Online or Set Up a Merchant Account - PayPal